Sign in

CIK 0001781983

  • Non-accelerated filer
  • Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-10-07 ROCKLAGE SCOTT M Director Conversion +492,475 2,418,548
2019-10-07 ROCKLAGE SCOTT M Director Conversion +20,519 100,772
2019-10-07 ROCKLAGE SCOTT M Director Conversion · Series B Convertible Preferred Stock −1,913,910 0
2019-10-07 ROCKLAGE SCOTT M Director Conversion · Series B Convertible Preferred Stock −79,746 0
2019-10-07 ROCKLAGE SCOTT M Director Conversion · Series C Convertible Preferred Stock −492,475 0
2019-10-07 ROCKLAGE SCOTT M Director Conversion · Series C Convertible Preferred Stock −20,519 0
2019-10-07 Magni Guido Director Purchase +6,500 $15.00 $98K 6,500
2019-10-07 HENNEMAN JOHN B III Director Purchase +5,000 $15.00 $75K 5,000
2019-10-07 HENNEMAN JOHN B III Director Grant or award · Stock Option (right to Buy) +18,407 18,407
2019-10-07 Korbel Gregory Alan VP of Business Dev't Purchase +500 $15.00 $8K 500
2019-10-07 Korbel Gregory Alan VP of Business Dev't Grant or award · Stock Option (right to Buy) +64,322 64,322
2019-10-07 Abrahmsen Lars B. SVP, Chief Scientific Officer Grant or award · Stock Option (right to Buy) +77,630 77,630
2019-10-07 Attar Eyal C. SVP, Chief Medical Officer Purchase +200 $15.00 $3K 200
2019-10-07 Attar Eyal C. SVP, Chief Medical Officer Purchase +200 $15.00 $3K 200
2019-10-07 Attar Eyal C. SVP, Chief Medical Officer Grant or award · Stock Option (right to Buy) +77,630 77,630
2019-10-07 Coiante Scott M SVP, Chief Financial Officer Purchase +2,500 $15.00 $38K 2,500
2019-10-07 Coiante Scott M SVP, Chief Financial Officer Grant or award · Stock Option (right to Buy) +150,824 150,824
2019-10-07 SCHADE CHRISTIAN S President & CEO Purchase +1,000 $15.00 $15K 1,000
2019-10-07 SCHADE CHRISTIAN S President & CEO Purchase +1,000 $15.00 $15K 1,000
2019-10-07 SCHADE CHRISTIAN S President & CEO Purchase +1,000 $15.00 $15K 1,000

Page 16 of 17 · 334 trades